M F Brennan

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer
    Abeezar I Sarela
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg Oncol 11:380-6. 2004
  2. ncbi Knowledge helps, but alone it is not enough
    Murray F Brennan
    Ann Surg Oncol 15:1555-6. 2008
  3. ncbi Pre-emptive surgery and increasing demands for technical perfection
    Murray F Brennan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Br J Surg 90:3-4. 2003
  4. ncbi Invited commentary: Surgery and chemotherapy for peritoneal carcinomatosis--more about selection and biology than treatment?
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Surgery 137:417-8. 2005
  5. ncbi Soft tissue sarcoma: advances in understanding and management
    M F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Surgeon 3:216-23. 2005
  6. ncbi The international medical graduate in the US surgical training system: perspectives of an aging warrior
    Murray F Brennan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Surgery 140:362-6. 2006
  7. ncbi Pancreatic cancer
    M F Brennan
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastroenterol Hepatol 15:G13-6. 2000
  8. ncbi Outcome--more than just operative mortality
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Surg Oncol 99:470-7. 2009
  9. ncbi Lessons learned
    Murray F Brennan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room H-1203, New York, NY 10021, USA
    Ann Surg Oncol 13:1322-8. 2006
  10. ncbi Randomized clinical trials in oncology commentary
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Surg Oncol Clin N Am 11:1-2, vii. 2002

Detail Information

Publications151 found, 100 shown here

  1. ncbi Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer
    Abeezar I Sarela
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg Oncol 11:380-6. 2004
    ..With accurate nodal staging, pN0 was associated with excellent prognosis. With pN+, prognosis was similar to that for gastric antral adenocarcinoma...
  2. ncbi Knowledge helps, but alone it is not enough
    Murray F Brennan
    Ann Surg Oncol 15:1555-6. 2008
  3. ncbi Pre-emptive surgery and increasing demands for technical perfection
    Murray F Brennan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Br J Surg 90:3-4. 2003
  4. ncbi Invited commentary: Surgery and chemotherapy for peritoneal carcinomatosis--more about selection and biology than treatment?
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Surgery 137:417-8. 2005
  5. ncbi Soft tissue sarcoma: advances in understanding and management
    M F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Surgeon 3:216-23. 2005
    ..Identification of targeted therapy utilising direct specific molecular targets raises hope that future progress in control, if not cure, is realistic...
  6. ncbi The international medical graduate in the US surgical training system: perspectives of an aging warrior
    Murray F Brennan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Surgery 140:362-6. 2006
  7. ncbi Pancreatic cancer
    M F Brennan
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastroenterol Hepatol 15:G13-6. 2000
    ..Advances in management are confined to more accurate preoperative diagnosis and staging, and decreased operative mortality. Long-term survival in the absence of resection remains poor...
  8. ncbi Outcome--more than just operative mortality
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    J Surg Oncol 99:470-7. 2009
    ..More current studies now relate long term cancer survival to other issues of specialization, volume, payor and institution. The challenge is to determine what volume thresholds are sufficient for acceptable outcomes...
  9. ncbi Lessons learned
    Murray F Brennan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Room H-1203, New York, NY 10021, USA
    Ann Surg Oncol 13:1322-8. 2006
  10. ncbi Randomized clinical trials in oncology commentary
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Surg Oncol Clin N Am 11:1-2, vii. 2002
    ..A brief description is given of three problems, which are how to bring the derived information into broad applicability, when are the results of a trial significant enough to make it a standard for care and the issue of quality control...
  11. ncbi Lifelong surgical education: adapt, change, or wither
    Murray F Brennan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Arch Surg 142:394-8. 2007
  12. ncbi Have you noticed?
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Institute, New York, NY, USA
    Surgery 137:389-90. 2005
  13. ncbi Adjuvant therapy following resection for pancreatic adenocarcinoma
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Surg Oncol Clin N Am 13:555-66, vii. 2004
    ..At the current time, given the relative failure of standard adjuvant approaches, it is reasonable to suggest that all patients should have tissue harvested for molecular markers and enter into investigative regimens...
  14. ncbi Safety in numbers
    M F Brennan
    Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Br J Surg 91:653-4. 2004
  15. ncbi Surgical education in the United States: portents for change
    Murray F Brennan
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg 240:565-72. 2004
  16. ncbi Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 240:293-8. 2004
    ..Predictive nomograms are becoming increasingly used to define and predict outcome. They can be developed at presentation or following treatment and include variables not conventionally used in standard staging systems...
  17. ncbi Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease
    K A Bickenbach
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, USA
    Ann Surg Oncol 19:1663-9. 2012
    ..The objective of this study was to evaluate outcome of initially unresectable patients who respond to multimodality therapy and undergo resection...
  18. ncbi Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment
    A Stojadinovic
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Arch Surg 136:70-9. 2001
    ..Complete surgical resection is the recommended treatment approach to achieve local control. Stratification by prognostic factors will facilitate selection of patients with STS for adjuvant systemic therapies...
  19. ncbi Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas
    C Cordon-Cardo
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021
    Cancer Res 54:794-9. 1994
    ..The overexpression of p53 and mdm2 proteins in the nuclei of tumor cells did not always correlate well with gene amplification at the mdm2 locus or mutation at the p53 gene. The possible reasons for these discrepancies are discussed...
  20. ncbi Characterization of molecular abnormalities in human fibroblastic neoplasms: a model for genotype-phenotype association in soft tissue tumors
    A Hoos
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer Res 61:3171-5. 2001
    ..pRB and Ki-67 status may be useful to predict recurrence in certain subsets of patients...
  21. ncbi Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time
    Jurgen Weitz
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 21:2719-25. 2003
    ..The objective of this study was to define whether survival of patients with extremity soft tissue sarcoma (STS), stratified for known risk factors, has improved over the last 20 years...
  22. ncbi Effect of reresection in extremity soft tissue sarcoma
    J J Lewis
    Departments of Surgery, Biostatistics, and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 231:655-63. 2000
    ..This study correlates reresection with local recurrence-free survival, metastasis-free survival, and disease-free survival...
  23. ncbi Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity
    J J Lewis
    Departments of Surgery, Biostatistics, and Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 18:2087-94. 2000
    ..The objective of this study was to determine independent prognostic factors of primary synovial sarcoma localized to the extremity...
  24. ncbi Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors
    A Hoos
    Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Am J Pathol 158:1245-51. 2001
    ..Concordance of triplicate cores is high (96 to 98%) for two category distinction and decreases with the complexity of the phenotypes being analyzed (91%)...
  25. ncbi Clinicopathologic analysis of patients with adult rhabdomyosarcoma
    W G Hawkins
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Cancer 91:794-803. 2001
    ..All histologic subtypes of RMS are aggressive malignancies with poor disease specific survival despite aggressive multimodality management...
  26. ncbi Impact of hospital volume on operative mortality for major cancer surgery
    C B Begg
    Department of Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    JAMA 280:1747-51. 1998
    ....
  27. ncbi Is intra-abdominal drainage necessary after pancreaticoduodenectomy?
    M J Heslin
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Gastrointest Surg 2:373-8. 1998
    ..Routine use of drains after pancreaticoduodenectomy may not be necessary and should be subjected to a randomized trial...
  28. ncbi Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer
    J L Dikken
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States
    Eur J Surg Oncol 38:319-25. 2012
    ..The aim of the present study is to determine whether preoperative chemotherapy is associated with any difference in the number of LNs obtained from specimens of patients who underwent curative surgery for gastric adenocarcinoma...
  29. ncbi Results of total pancreatectomy for adenocarcinoma of the pancreas
    H M Karpoff
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Arch Surg 136:44-7; discussion 48. 2001
    ..In patients who require total pancreatectomy for ductal adenocarcinoma, the survival is so poor as to bring into question the value of the operation...
  30. ncbi Liver resection for colorectal metastases
    Y Fong
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 15:938-46. 1997
    ..The current study was performed to determine if liver resection for colorectal metastases is safe and effective and to evaluate predictors of outcome...
  31. ncbi Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma
    J J Lewis
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Arch Surg 134:190-4. 1999
    ..The majority of survival studies in patients with extremity soft tissue sarcoma have focused on early recurrence and mortality. There are few data addressing long-term follow-up and survival...
  32. ncbi Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    John C Mansour
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 14:3412-8. 2007
    ..After publication of the MAGIC trial results, preoperative chemotherapy is increasingly used to treat advanced gastric cancer before resection. Tools for measuring response must be assessed...
  33. ncbi Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors
    Narasimhan P Agaram
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Cancer Res 13:170-81. 2007
    ..Our goal was to investigate the spectrum of pathologic response and molecular alterations in a group of GIST patients, clinically defined as having imatinib-stable/imatinib-responsive lesions, who underwent surgical resection...
  34. ncbi The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma
    Fritz C Eilber
    Departments of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    Ann Surg 240:686-95; discussion 695-7. 2004
    ..Treatment with IF should be considered in patients with high-risk primary extremity liposarcoma...
  35. ncbi Gastric carcinoma
    M S Karpeh
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 5:650-6. 1998
    ....
  36. ncbi Intralesional resection of primary and metastatic sarcoma involving the spine: outcome analysis of 59 patients
    M H Bilsky
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Neurosurgery 49:1277-86; discussion 1286-7. 2001
    ..This study is a retrospective analysis of the long-term outcomes of patients who had operations for sarcomas of the spine using modern surgical approaches, intralesional resections, and spinal instrumentation...
  37. ncbi Adult perineal sarcomas
    S R Grobmyer
    Department of Surgery, Memorial-Sloan Kettering Cancer Center, New York, New York, USA
    J Surg Oncol 77:101-4. 2001
    ..CONCLUSIONS: Aggressive therapy and follow-up beginning with wide excision can be associated with long-term survival in adults with primary perineal sarcoma...
  38. ncbi Vascular soft-tissue sarcomas. An analysis of tumor-related mortality
    M S Karpeh
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021
    Arch Surg 126:1474-81. 1991
    ..The survival of these patients depends on complete surgical resection and is independent of individual histologic characteristics of the tumor...
  39. ncbi Malignant pancreatic tumors in childhood and adolescence: The Memorial Sloan-Kettering experience, 1967 to present
    Nicholas A Shorter
    Department of Surgery and Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    J Pediatr Surg 37:887-92. 2002
    ..However, the risk of recurrence for pancreatoblastoma is high. The roles of chemotherapy and radiation remain undefined...
  40. ncbi An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma
    Alexander Stojadinovic
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 196:954-64. 2003
    ..CONCLUSIONS: Surgical resection remains the only potentially curative therapy for adenocarcinoma of the pancreas. There is no clear indication as to a single preferable resection approach...
  41. ncbi Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma
    Jason S Gold
    Department of Surgery, VA Boston Healthcare System Brigham and Women s Hospital, West Roxbury, Massachusetts, USA
    Ann Surg Oncol 14:3159-67. 2007
    ..We tested the utility of a nomogram created for determining disease-specific survival (DSS) after R0 resection of gastric cancer in estimating DSS for patients with resected duodenal cancer...
  42. ncbi Treatment of retroperitoneal sarcomas
    Stephen R Grobmyer
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    Adv Surg 38:13-29. 2004
  43. ncbi Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk
    Kimberly Moore Dalal
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 244:381-91. 2006
    ..DSS nomograms aid in more accurate counseling of patients, identification of patients appropriate for adjuvant therapy, and stratification of patients for clinical trials and molecular analysis...
  44. ncbi Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience
    J N Vauthey
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 2:126-31. 1995
    ..Prior studies have shown a high rate of local recurrence and a dismal overall prognosis in malignant peripheral nerve sheath tumors (MPNSTs)...
  45. ncbi Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity
    K M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 48:1051-8. 2000
    ..The purpose of this study was to determine if adjuvant RT improves local control in patients with high-grade STS who had positive margins of resection...
  46. ncbi A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer
    B Brenner
    Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Cornell University of New York, New York 10021, USA
    Ann Oncol 17:1404-11. 2006
    ..p. FUdR/LV can be safely delivered to patients undergoing radical gastrectomy and D2 lymphadenectomy. The R0 resection and the survival rates are encouraging. An association between pathologic response and patient outcome was suggested...
  47. ncbi Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas
    M S Karpeh
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Br J Cancer 72:986-91. 1995
    ..It is postulated that RB alterations are primary events in human sarcomas and may be involved in tumorigenesis or early phases of tumour progression in these neoplasias...
  48. ncbi Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma
    R C Fields
    Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Br J Cancer 104:1840-7. 2011
    ..To characterise recurrence patterns and survival following pathologic complete response (pCR) in patients who received preoperative therapy for localised gastric or gastrooesophageal junction (GEJ) adenocarcinoma...
  49. ncbi Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection
    K C Conlon
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Ann Surg 234:487-93; discussion 493-4. 2001
    ..Based on these results, closed suction drainage should not be considered mandatory or standard after pancreatic resection...
  50. ncbi Soft tissue sarcomas of the groin: diagnosis, management, and prognosis
    A D Brooks
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 193:130-6. 2001
    ..The biology of these tumors is similar to other extremity STS, and similar principles of management apply. Even with neurovascular involvement, most patients with primary groin STS do not require amputation...
  51. ncbi Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison
    B M Clary
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:290-9. 2001
    ..The pattern of distant spread follows the known patterns of hematogenous dissemination. Complete surgical resection is the cornerstone of treatment for primary GIST and LMS and in selected patients with local and distant recurrence...
  52. ncbi Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcome
    A Stojadinovic
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 8:509-18. 2001
    ..Amputation improves local disease control but not survival under these circumstances...
  53. ncbi Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity?
    Jonathan B Koea
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 10:432-40. 2003
    ..We attempted to define the effect of tumor histotype on local recurrence, distant metastasis, and disease-specific survival in patients with surgically treated primary extremity sarcoma...
  54. ncbi Accurate lymph node staging is of greater prognostic importance than subclassification of the T2 category for gastric adenocarcinoma
    Abeezar I Sarela
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 10:783-91. 2003
    ..44%). pN2 or pN3 were mainly limited to SS tumors and these patients had poor survival (26% and 0%). CONCLUSION: For pT2 gastric adenocarcinoma, the depth of mural invasion was not an independently significant prognostic factor...
  55. ncbi Is there a role for staging laparoscopy in patients with locally advanced, unresectable pancreatic adenocarcinoma?
    Margo Shoup
    From the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Gastrointest Surg 8:1068-71. 2004
    ..Patients considered for treatment protocols for locally unresectable pancreatic cancer should be staged laparoscopically before initiation of therapy...
  56. ncbi Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?
    Rebecca A Gladdy
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Howard 1209, New York, NY 10065, USA
    J Clin Oncol 28:2064-9. 2010
    ..DSS in patients with primary RAS is significantly worse compared with sporadic STS independent of sarcoma histologic type...
  57. ncbi Long-term outcomes in extremity soft tissue sarcoma after a pathologically negative re-resection and without radiotherapy
    Oren Cahlon
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 112:2774-9. 2008
    ....
  58. ncbi Long-term results with resection of radiation-induced soft tissue sarcomas
    Charles Cha
    Surgical Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    Ann Surg 239:903-9; discussion 909-10. 2004
    ..Surgical resection remains the primary therapy, but 5-year survival remains approximately 40%...
  59. ncbi Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor
    Ronald P Dematteo
    Hepatobiliary Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    Curr Probl Surg 40:144-93. 2003
  60. ncbi Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups
    Steven N Hochwald
    Department of Surgery, University of Florida College of Medicine, Gainesville, FL, USA
    J Clin Oncol 20:2633-42. 2002
    ..An alternative system based on mitotic rate and necrosis correlates strongly with survival without specifically designating any group as benign...
  61. ncbi Current status of surgery for gastric cancer: a review
    Murray F Brennan
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Gastric Cancer 8:64-70. 2005
    ..The international gastric cancer community can help define the important issues that need to be answered in the coming decades...
  62. ncbi Why do patients with low-grade soft tissue sarcoma die?
    Robert J Canter
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg Oncol 15:3550-60. 2008
    ..The patterns of failure and mechanisms of sarcoma-specific death are poorly characterized among the minority of patients with low-grade soft tissue sarcoma (STS) who succumb to disease...
  63. ncbi Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma
    Abeezar I Sarela
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Ann Surg 243:189-95. 2006
    ..Intervention-related mortality was minimal. The burden of metastatic disease and functional performance status were important prognostic factors...
  64. ncbi Results of hepatic resection for sarcoma metastatic to liver
    R P DeMatteo
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg 234:540-7; discussion 547-8. 2001
    ..Hepatectomy should be considered when complete gross resection is possible, especially when the time to the development of liver metastasis exceeds 2 years...
  65. ncbi The clinical approach to desmoplastic small round cell tumor
    M P Quaglia
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Surg Oncol 9:77-81. 2000
    ..Conclusion: We recommend induction chemotherapy (P6) followed by aggressive surgical debulking and external beam radiotherapy for the treatment of DSRCT. Further progress will require new forms of treatment...
  66. ncbi Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy
    S P Povoski
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Gastrointest Surg 3:496-505. 1999
    ..These data suggest that preoperative biliary drainage should be avoided in candidates for pancreaticoduodenectomy...
  67. ncbi Hürthle cell carcinoma: a critical histopathologic appraisal
    A Stojadinovic
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 19:2616-25. 2001
    ..Unlike differentiated thyroid cancer, nodal metastases predict a worse outcome in widely invasive Hürthle cell carcinoma, as does extrathyroidal extension...
  68. ncbi Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model
    W R Jarnagin
    Departments of Surgery and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 231:762-71. 2000
    ..To evaluate the neoadjuvant use of a herpes simplex viral (HSV) amplicon vector expressing the murine interleukin-12 (IL-12) gene...
  69. ncbi Is extended resection for adenocarcinoma of the body or tail of the pancreas justified?
    Margo Shoup
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 7:946-52; discussion 952. 2003
    ..Extended distal pancreatectomy is justified in this group of patients...
  70. ncbi Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram
    Rebekah R White
    Department of Surgical Oncology, Memorial Sloan-Kettering Cancer Center, New York 10021, USA
    Ann Surg Oncol 13:1485-92. 2006
    ..The ability of the nomogram to evaluate the effects of preop CRT on survival is limited by the potential effects of preop CRT on factors within the nomogram...
  71. ncbi Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma
    Michael W Kattan
    Department of Urology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, C1275 New York, NY 10021, USA
    J Clin Oncol 21:3647-50. 2003
    ..This tool should be useful for patient counseling, follow-up scheduling, and clinical trial eligibility determination...
  72. ncbi Outcome of metastatic GIST in the era before tyrosine kinase inhibitors
    Jason S Gold
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 14:134-42. 2007
    ..Treatment of metastatic GIST with imatinib mesylate results in a 2-year survival of approximately 72%. The outcome of patients with metastatic GIST not treated with tyrosine kinase inhibitors is not well defined...
  73. ncbi Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram
    Vivian E Strong
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg 251:640-6. 2010
    ..To compare disease-specific survival (DSS) between the US and Korea following R0 resection for gastric carcinoma (GC)...
  74. ncbi Extended local resection for advanced gastric cancer: increased survival versus increased morbidity
    Robert C G Martin
    Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 236:159-65. 2002
    ..Additional organ resection can be performed with minimal morbidity and can improve the chance of overall survival in patients with advanced T-stage disease...
  75. ncbi Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule
    James O Park
    Soft Tissue Sarcoma Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 250:977-82. 2009
    ..To identify the prognostic variables that predict disease-specific survival and second local recurrence-free survival in patients with recurrent retroperitoneal liposarcoma so as to guide clinical management...
  76. ncbi The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma
    Cristina R Ferrone
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 10:1347-53. 2006
    ..23% negative; P=0.006). In this study, patients who underwent resection in the presence of positive peritoneal cytology and absence of other identifiable metastatic disease had a similar survival as other patients with stage IV disease...
  77. ncbi Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma
    Shishir K Maithel
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg Oncol 15:3512-20. 2008
    ..Factors associated with the likelihood of subradiographic unresectable disease have not been clearly defined...
  78. ncbi Role of fine-needle aspiration biopsy and frozen section analysis in the surgical management of thyroid tumors
    A D Brooks
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 8:92-100. 2001
    ..Intraoperative FS added very little to surgical management. The majority of thyroid operations at this institution are planned and performed based on known prognostic factors and intraoperative findings...
  79. ncbi Laparoscopy predicts metastatic disease and spares laparotomy in selected patients with pancreatic nonfunctioning islet cell tumors
    S N Hochwald
    Department of Surgery, University of Florida College of Medicine, Gainesville, USA
    Ann Surg Oncol 8:249-53. 2001
    ..Despite metastatic disease, prolonged survival is often achieved with or without open surgical treatment. Laparoscopy can be used in diagnosis and accurately identifies metastases not seen on CT, thus sparing laparotomy in some patients...
  80. ncbi High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas
    A Hoos
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Cancer 92:869-74. 2001
    ....
  81. ncbi Surgical oncology fellowship: viable pathway to academic surgery?
    M J Heslin
    Department of Surgery Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 6:542-5. 1999
    ..Data that document academic status after surgical oncology fellowship are sparse. This study was done to report the academic status and clinical practice of graduates of a major surgical oncology program...
  82. ncbi Post-treatment sarcoma in breast cancer patients
    M S Brady
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021
    Ann Surg Oncol 1:66-72. 1994
    ..Many patients treated for breast cancer with radiotherapy will survive their disease and be at risk for treatment-related sarcoma for many years...
  83. ncbi Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunk
    K M Alektiar
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 47:1273-9. 2000
    ..The purpose of this study was to evaluate the toxicity associated with adjuvant BRT in terms of wound complications, bone fracture, and peripheral nerve damage...
  84. ncbi Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma
    Mario M Leitao
    Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Gynecol Oncol 87:287-94. 2002
    ..Time to first recurrence and optimal surgical resection were predictors of improved outcome in this study...
  85. ncbi Influence of compartmental involvement on the patterns of morbidity in soft tissue sarcoma of the thigh
    Andreas Rimner
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 115:149-57. 2009
    ..The authors sought to determine whether differences existed in patterns of outcome and morbidity between the 3 thigh compartments after limb-sparing surgery and postoperative radiation therapy (RT)...
  86. ncbi Neoadjuvant therapy for gastric cancer
    Michael G House
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Adv Surg 42:151-68. 2008
    ..Patients who are determined to have high-risk disease postoperatively should be offered adjuvant therapy that will address the site of recurrence most likely to affect survival...
  87. ncbi Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysis
    Robert J Canter
    Division of Surgical Oncology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 110:2050-60. 2007
    ..To the authors' knowledge, few studies to date have examined the effect of chemotherapy in patients undergoing pulmonary resection for metastatic STS of the extremity...
  88. ncbi The role of pulmonary metastasectomy in soft tissue sarcoma
    Larissa K F Temple
    Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Semin Thorac Cardiovasc Surg 14:35-44. 2002
    ..Future research is needed to better identify patients for metastasectomy, to determine the role of minimally invasive procedures, and to develop better adjuvant therapy...
  89. ncbi Limitations of ampullectomy in the treatment of nonfamilial ampullary neoplasms
    Kevin K Roggin
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 12:971-80. 2005
    ..Conversion to PD should be considered when intraoperative or final pathology identifies invasive adenocarcinoma. Refinement of clinicopathologic factors may reduce the occasional PD for benign disease and AMP for malignancy...
  90. ncbi Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome
    Andrew P Barbour
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 14:306-16. 2007
    ..The aim of this study was to determine whether adequate staging revealed different prognostic factors or improved survival compared with patients with <15 nodes examined after R0 resection for GEJ cancer...
  91. ncbi Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction
    Andrew P Barbour
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 205:593-601. 2007
    ..The purpose of this study was to compare preoperative EUS staging with postoperative pathologic staging and to assess the ability of EUS to predict survival after resection for GEJ adenocarcinoma...
  92. ncbi Achieving RO resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?
    Robert C G Martin
    Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 194:568-77. 2002
    ..Given the potential for increased morbidity and mortality from multiple organ resection we asked the question as to whether extended (multiple organ) resection was justified for advanced gastric cancer...
  93. ncbi The value of laparoscopy in the management of ampullary, duodenal, and distal bile duct tumors
    Ari D Brooks
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    J Gastrointest Surg 6:139-45; discussion 145-6. 2002
    ..We believe that laparoscopy should be used in a selective manner for preoperative staging of patients suspected of having nonpancreatic periampullary tumors...
  94. ncbi Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients
    N Volkan Adsay
    Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 1002, USA
    Cancer 94:62-77. 2002
    ....
  95. ncbi Adult spermatic cord sarcomas: management and results
    Jonathan Coleman
    Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 10:669-75. 2003
    ..CONCLUSIONS: We demonstrated that aggressive surgical strategies, including reoperative wide resection, significantly decrease local recurrence and may improve disease free-survival in select patients with spermatic cord sarcoma...
  96. ncbi Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?
    Hong Jin Kim
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Gastrointest Surg 6:763-9. 2002
    ..Novel multimodality approaches are required...
  97. ncbi Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer
    Jurgen Weitz
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 21:4597-603. 2003
    ....
  98. ncbi Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution
    Michael G House
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 210:744-52, 752-5. 2010
    ..This study analyzes factors associated with differences in long-term outcomes after hepatic resection for metastatic colorectal cancer over time...
  99. ncbi Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma
    Kaori Ito
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Surg 251:675-81. 2010
    ..To examine the importance of adequate lymph node sampling in staging of extrahepatic bile duct cancer (EHBDCA)...
  100. ncbi Predictive variables detailing the recurrence rate of soft tissue sarcomas
    Stephen R Grobmyer
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Opin Oncol 15:319-26. 2003
    ..Emerging areas in predicting outcome of patients with soft tissue sarcoma include response to neoadjuvant chemotherapy and molecular markers...
  101. ncbi Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases
    C R Antonescu
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Cancer Res 7:3977-87. 2001
    ..We also analyzed P53 status, because this parameter has been found to have a significant prognostic impact in other sarcomas with chromosomal translocations...